287 related articles for article (PubMed ID: 17177177)
1. Loss of imprinting and cancer.
Jelinic P; Shaw P
J Pathol; 2007 Feb; 211(3):261-8. PubMed ID: 17177177
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
[TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
[TBL] [Abstract][Full Text] [Related]
5. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
7. Imprinting of the mouse Igf2r gene depends on an intronic CpG island.
Wutz A; Barlow DP
Mol Cell Endocrinol; 1998 May; 140(1-2):9-14. PubMed ID: 9722161
[TBL] [Abstract][Full Text] [Related]
8. [Epigenetics, genomic imprinting and developmental disorders].
Le Bouc Y; Rossignol S; Azzi S; Brioude F; Cabrol S; Gicquel C; Netchine I
Bull Acad Natl Med; 2010 Feb; 194(2):287-97; discussion 297-300. PubMed ID: 21166119
[TBL] [Abstract][Full Text] [Related]
9. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
[TBL] [Abstract][Full Text] [Related]
10. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic differences between Wilms' tumours in white and east-Asian children.
Fukuzawa R; Breslow NE; Morison IM; Dwyer P; Kusafuka T; Kobayashi Y; Becroft DM; Beckwith JB; Perlman EJ; Reeve AE
Lancet; 2004 Feb; 363(9407):446-51. PubMed ID: 14962525
[TBL] [Abstract][Full Text] [Related]
14. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
15. Paternal imprints can be established on the maternal Igf2-H19 locus without altering replication timing of DNA.
Cerrato F; Dean W; Davies K; Kagotani K; Mitsuya K; Okumura K; Riccio A; Reik W
Hum Mol Genet; 2003 Dec; 12(23):3123-32. PubMed ID: 14532328
[TBL] [Abstract][Full Text] [Related]
16. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
[TBL] [Abstract][Full Text] [Related]
17. Imprinting, expression, and localisation of DLK1 in Wilms tumours.
Fukuzawa R; Heathcott RW; Morison IM; Reeve AE
J Clin Pathol; 2005 Feb; 58(2):145-50. PubMed ID: 15677533
[TBL] [Abstract][Full Text] [Related]
18. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.
Frevel MA; Sowerby SJ; Petersen GB; Reeve AE
J Biol Chem; 1999 Oct; 274(41):29331-40. PubMed ID: 10506193
[TBL] [Abstract][Full Text] [Related]
19. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development.
Weksberg R; Smith AC; Squire J; Sadowski P
Hum Mol Genet; 2003 Apr; 12 Spec No 1():R61-8. PubMed ID: 12668598
[TBL] [Abstract][Full Text] [Related]
20. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
